Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulka Vaishampayan

Showing results (11-20 of 176) with videos related to

Pageof 18
Sort By:
Current Treatment Options in Oncology|March 14, 2017
Cabozantinib for Renal Cell Carcinoma: Current and Future ParadigmsAhmed Abdelaziz, Ulka Vaishampayan
Expert Review of Anticancer Therapy|February 19, 2008
Update in systemic therapy of prostate cancer: improvement in quality and duration of lifeUlka Vaishampayan, Maha Hussain
Oncology and Therapy|October 2, 2024
Understanding Treatment Decisions and Management for Patients with Advanced Renal Cell Carcinoma Using Hypothetical Case Studies: A VodcastBenjamin Garmezy, Ulka Vaishampayan
Expert Review of Anticancer Therapy|June 22, 2017
Cabozantinib for the treatment of kidney cancerAhmed Abdelaziz, Ulka Vaishampayan
Clinical Advances in Hematology & Oncology : H&O|June 9, 2020
Perioperative approaches to kidney cancerKennedy Iheanacho, Ulka Vaishampayan
Current Opinion in Oncology|March 19, 2016
Multifaceted and personalized therapy of advanced prostate cancerManish K Thakur, Ulka Vaishampayan
Journal of Kidney Cancer and VHL|November 22, 2019
Predictors of Cytoreductive Nephrectomy for Metastatic Kidney Cancer in SEER and Metropolitan Detroit DatabasesUlka Vaishampayan, Julie George, Fawn Vigneau
European Urology Focus|January 17, 2025
Clinical Applications of Microbiome in Renal Cell CarcinomaSara Elyas, Pedro Barata, Ulka Vaishampayan
Urologic Oncology|March 6, 2017
Nivolumab treatment for advanced renal cell carcinoma: Considerations for clinical practiceRichard W Joseph, Gurkamal Chatta, Ulka Vaishampayan
Cancers|November 13, 2013
Immunotherapy and immune evasion in prostate cancerArchana Thakur, Ulka Vaishampayan, Lawrence G Lum
Pageof 18

Showing results (11-20 of 176) with videos related to

Sort By:
Pageof 18
Current Treatment Options in Oncology|March 14, 2017
Cabozantinib for Renal Cell Carcinoma: Current and Future ParadigmsAhmed Abdelaziz, Ulka Vaishampayan
Expert Review of Anticancer Therapy|February 19, 2008
Update in systemic therapy of prostate cancer: improvement in quality and duration of lifeUlka Vaishampayan, Maha Hussain
Oncology and Therapy|October 2, 2024
Understanding Treatment Decisions and Management for Patients with Advanced Renal Cell Carcinoma Using Hypothetical Case Studies: A VodcastBenjamin Garmezy, Ulka Vaishampayan
Expert Review of Anticancer Therapy|June 22, 2017
Cabozantinib for the treatment of kidney cancerAhmed Abdelaziz, Ulka Vaishampayan
Clinical Advances in Hematology & Oncology : H&O|June 9, 2020
Perioperative approaches to kidney cancerKennedy Iheanacho, Ulka Vaishampayan
Current Opinion in Oncology|March 19, 2016
Multifaceted and personalized therapy of advanced prostate cancerManish K Thakur, Ulka Vaishampayan
Journal of Kidney Cancer and VHL|November 22, 2019
Predictors of Cytoreductive Nephrectomy for Metastatic Kidney Cancer in SEER and Metropolitan Detroit DatabasesUlka Vaishampayan, Julie George, Fawn Vigneau
European Urology Focus|January 17, 2025
Clinical Applications of Microbiome in Renal Cell CarcinomaSara Elyas, Pedro Barata, Ulka Vaishampayan
Urologic Oncology|March 6, 2017
Nivolumab treatment for advanced renal cell carcinoma: Considerations for clinical practiceRichard W Joseph, Gurkamal Chatta, Ulka Vaishampayan
Cancers|November 13, 2013
Immunotherapy and immune evasion in prostate cancerArchana Thakur, Ulka Vaishampayan, Lawrence G Lum
Pageof 18